APO Research
Talk to an analyst

APO RESEARCH · REPORT

Point-of-Care Testing (POCT)

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Selected research

Industry Growth & Trends

Global Point-of-Care Testing (POCT) Industry Growth and Trends Forecast to 2032

21 December 2025125 pages

Choose your research edition.

Industry ResearchPoint-of-Care Testing (POCT) Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Point-of-Care Testing (POCT) Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Point-of-Care Testing (POCT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Point-of-Care Testing (POCT) Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Point-of-Care Testing (POCT) Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Point-of-Care Testing (POCT) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Point-of-Care Testing (POCT) market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Point-of-Care Testing (POCT) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Point-of-Care Testing (POCT).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Point-of-Care Testing (POCT) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Point-of-Care Testing (POCT) Market by Company

Roche

Abbott

Johnson & Johnson

Siemens Healthcare

Danaher

Ascensia

Bio-Rad Laboratories

BioMerieux

ARKRAY

Nova Biomedical

Trividia Health

Quidel

Accriva

OraSure Technologies

Helena Laboratories

A. Menarini Diagnostics

Abaxis (Zoetis)

Ortho Clinical Diagnostics

Phamatech

Chembio Diagnostics

Trinity Biotech

ELITech Group

Response Biomedical

Princeton BioMeditech

Alfa Wassermann

Point-of-Care Testing (POCT) Segment by Type

Blood Glucose Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Pregnancy and Fertility Testing

Blood Gas/Electrolytes Testing

Urinalysis Testing

Point-of-Care Testing (POCT) Segment by Application

Clinics

Hospitals

Laboratory

Others

Point-of-Care Testing (POCT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Blood Glucose Testing Table 2. Major Company of Infectious Diseases Testing Table 3. Major Company of Cardiac Markers Testing Table 4. Major Company of Coagulation Testing Table 5. Major Company of Pregnancy and Fertility Testing Table 6. Major Company of Blood Gas/Electrolytes Testing Table 7. Major Company of Urinalysis Testing Table 8. Global Point-of-Care Testing (POCT) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 10. Global Point-of-Care Testing (POCT) Sales Market Share in Volume by Type (2021-2026) Table 11. Global Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (US$ Million) Table 12. Global Point-of-Care Testing (POCT) Sales Market Share in Value by Type (2021-2026) Table 13. Global Point-of-Care Testing (POCT) Price by Type (2021-2026) & (USD/Unit) Table 14. Global Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (M Units) Table 15. Global Point-of-Care Testing (POCT) Sales Market Share in Volume by Type (2027-2032) Table 16. Global Point-of-Care Testing (POCT) Sales by Type (2027-2032) & (US$ Million) Table 17. Global Point-of-Care Testing (POCT) Sales Market Share in Value by Type (2027-2032) Table 18. Global Point-of-Care Testing (POCT) Price by Type (2027-2032) & (USD/Unit) Table 19. North America Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 20. North America Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 22. Europe Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 24. Asia-Pacific Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 26. Latin America Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (M Units) Table 28. Middle East and Africa Point-of-Care Testing (POCT) Sales by Type (2021-2026) & (US$ Million) Table 29. Point-of-Care Testing (POCT) Industry Trends Table 30. Point-of-Care Testing (POCT) Industry Drivers Table 31. Point-of-Care Testing (POCT) Industry Opportunities and Challenges Table 32. Point-of-Care Testing (POCT) Industry Restraints Table 33. Global Point-of-Care Testing (POCT) Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Point-of-Care Testing (POCT) Revenue Market Share by Company (2021-2026) Table 35. Global Point-of-Care Testing (POCT) Sales by Company (2021-2026) & (M Units) Table 36. Global Point-of-Care Testing (POCT) Sales Share by Company (2021-2026) Table 37. Global Point-of-Care Testing (POCT) Market Price by Company (2021-2026) & (USD/Unit) Table 38. Global Point-of-Care Testing (POCT) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Point-of-Care Testing (POCT) Major Company Production Sites and Headquarters Table 40. Global Point-of-Care Testing (POCT) Company, Product Type & Application Table 41. Global Point-of-Care Testing (POCT) Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Point-of-Care Testing (POCT) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Point-of-Care Testing (POCT) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Point-of-Care Testing (POCT) Sales by Region (2021-2026) & (M Units) Table 46. Global Point-of-Care Testing (POCT) Sales Market Share in Volume by Region (2021-2026) Table 47. Global Point-of-Care Testing (POCT) Sales by Region (2021-2026) & (US$ Million) Table 48. Global Point-of-Care Testing (POCT) Sales Market Share in Value by Region (2021-2026) Table 49. Global Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 50. Global Point-of-Care Testing (POCT) Sales by Region (2027-2032) & (M Units) Table 51. Global Point-of-Care Testing (POCT) Sales Market Share in Volume by Region (2027-2032) Table 52. Global Point-of-Care Testing (POCT) Sales by Region (2027-2032) & (US$ Million) Table 53. Global Point-of-Care Testing (POCT) Sales Market Share in Value by Region (2027-2032) Table 54. Global Point-of-Care Testing (POCT) Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 55. Global Point-of-Care Testing (POCT) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 57. Global Point-of-Care Testing (POCT) Sales Market Share in Volume by Application (2021-2026) Table 58. Global Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (US$ Million) Table 59. Global Point-of-Care Testing (POCT) Sales Market Share in Value by Application (2021-2026) Table 60. Global Point-of-Care Testing (POCT) Price by Application (2021-2026) & (USD/Unit) Table 61. Global Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (M Units) Table 62. Global Point-of-Care Testing (POCT) Sales Market Share in Volume by Application (2027-2032) Table 63. Global Point-of-Care Testing (POCT) Sales by Application (2027-2032) & (US$ Million) Table 64. Global Point-of-Care Testing (POCT) Sales Market Share in Value by Application (2027-2032) Table 65. Global Point-of-Care Testing (POCT) Price by Application (2027-2032) & (USD/Unit) Table 66. North America Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 67. North America Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 69. Europe Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 71. Asia-Pacific Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 73. Latin America Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (M Units) Table 75. Middle East and Africa Point-of-Care Testing (POCT) Sales by Application (2021-2026) & (US$ Million) Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Roche Point-of-Care Testing (POCT) Product Portfolio Table 80. Roche Recent Development Table 81. Abbott Company Information Table 82. Abbott Business Overview Table 83. Abbott Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Abbott Point-of-Care Testing (POCT) Product Portfolio Table 85. Abbott Recent Development Table 86. Johnson & Johnson Company Information Table 87. Johnson & Johnson Business Overview Table 88. Johnson & Johnson Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio Table 90. Johnson & Johnson Recent Development Table 91. Siemens Healthcare Company Information Table 92. Siemens Healthcare Business Overview Table 93. Siemens Healthcare Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio Table 95. Siemens Healthcare Recent Development Table 96. Danaher Company Information Table 97. Danaher Business Overview Table 98. Danaher Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Danaher Point-of-Care Testing (POCT) Product Portfolio Table 100. Danaher Recent Development Table 101. Ascensia Company Information Table 102. Ascensia Business Overview Table 103. Ascensia Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Ascensia Point-of-Care Testing (POCT) Product Portfolio Table 105. Ascensia Recent Development Table 106. Bio-Rad Laboratories Company Information Table 107. Bio-Rad Laboratories Business Overview Table 108. Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 110. Bio-Rad Laboratories Recent Development Table 111. BioMerieux Company Information Table 112. BioMerieux Business Overview Table 113. BioMerieux Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. BioMerieux Point-of-Care Testing (POCT) Product Portfolio Table 115. BioMerieux Recent Development Table 116. ARKRAY Company Information Table 117. ARKRAY Business Overview Table 118. ARKRAY Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. ARKRAY Point-of-Care Testing (POCT) Product Portfolio Table 120. ARKRAY Recent Development Table 121. Nova Biomedical Company Information Table 122. Nova Biomedical Business Overview Table 123. Nova Biomedical Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 125. Nova Biomedical Recent Development Table 126. Trividia Health Company Information Table 127. Trividia Health Business Overview Table 128. Trividia Health Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Trividia Health Point-of-Care Testing (POCT) Product Portfolio Table 130. Trividia Health Recent Development Table 131. Quidel Company Information Table 132. Quidel Business Overview Table 133. Quidel Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Quidel Point-of-Care Testing (POCT) Product Portfolio Table 135. Quidel Recent Development Table 136. Accriva Company Information Table 137. Accriva Business Overview Table 138. Accriva Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Accriva Point-of-Care Testing (POCT) Product Portfolio Table 140. Accriva Recent Development Table 141. OraSure Technologies Company Information Table 142. OraSure Technologies Business Overview Table 143. OraSure Technologies Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio Table 145. OraSure Technologies Recent Development Table 146. Helena Laboratories Company Information Table 147. Helena Laboratories Business Overview Table 148. Helena Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 149. Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio Table 150. Helena Laboratories Recent Development Table 151. A. Menarini Diagnostics Company Information Table 152. A. Menarini Diagnostics Business Overview Table 153. A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 154. A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 155. A. Menarini Diagnostics Recent Development Table 156. Abaxis (Zoetis) Company Information Table 157. Abaxis (Zoetis) Business Overview Table 158. Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 159. Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio Table 160. Abaxis (Zoetis) Recent Development Table 161. Ortho Clinical Diagnostics Company Information Table 162. Ortho Clinical Diagnostics Business Overview Table 163. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 164. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 165. Ortho Clinical Diagnostics Recent Development Table 166. Phamatech Company Information Table 167. Phamatech Business Overview Table 168. Phamatech Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 169. Phamatech Point-of-Care Testing (POCT) Product Portfolio Table 170. Phamatech Recent Development Table 171. Chembio Diagnostics Company Information Table 172. Chembio Diagnostics Business Overview Table 173. Chembio Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 174. Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio Table 175. Chembio Diagnostics Recent Development Table 176. Trinity Biotech Company Information Table 177. Trinity Biotech Business Overview Table 178. Trinity Biotech Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 179. Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio Table 180. Trinity Biotech Recent Development Table 181. ELITech Group Company Information Table 182. ELITech Group Business Overview Table 183. ELITech Group Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 184. ELITech Group Point-of-Care Testing (POCT) Product Portfolio Table 185. ELITech Group Recent Development Table 186. Response Biomedical Company Information Table 187. Response Biomedical Business Overview Table 188. Response Biomedical Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 189. Response Biomedical Point-of-Care Testing (POCT) Product Portfolio Table 190. Response Biomedical Recent Development Table 191. Princeton BioMeditech Company Information Table 192. Princeton BioMeditech Business Overview Table 193. Princeton BioMeditech Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 194. Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio Table 195. Princeton BioMeditech Recent Development Table 196. Alfa Wassermann Company Information Table 197. Alfa Wassermann Business Overview Table 198. Alfa Wassermann Point-of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 199. Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio Table 200. Alfa Wassermann Recent Development Table 201. North America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 202. North America Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 203. North America Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2026) Table 204. North America Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032) & (M Units) Table 205. North America Point-of-Care Testing (POCT) Sales Market Share Forecast by Country (2027-2032) Table 206. North America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. North America Point-of-Care Testing (POCT) Market Size by Country (2021-2026) & (US$ Million) Table 208. North America Point-of-Care Testing (POCT) Market Share by Country (2021-2026) Table 209. North America Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. North America Point-of-Care Testing (POCT) Market Share Forecast by Country (2027-2032) Table 211. Europe Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 212. Europe Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 213. Europe Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2026) Table 214. Europe Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032) & (M Units) Table 215. Europe Point-of-Care Testing (POCT) Sales Market Share Forecast by Country (2027-2032) Table 216. Europe Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Europe Point-of-Care Testing (POCT) Market Size by Country (2021-2026) & (US$ Million) Table 218. Europe Point-of-Care Testing (POCT) Market Share by Country (2021-2026) Table 219. Europe Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Europe Point-of-Care Testing (POCT) Market Share Forecast by Country (2027-2032) Table 221. Asia-Pacific Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 222. Asia-Pacific Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 223. Asia-Pacific Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2026) Table 224. Asia-Pacific Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032) & (M Units) Table 225. Asia-Pacific Point-of-Care Testing (POCT) Sales Market Share Forecast by Country (2027-2032) Table 226. Asia-Pacific Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. Asia-Pacific Point-of-Care Testing (POCT) Market Size by Country (2021-2026) & (US$ Million) Table 228. Asia-Pacific Point-of-Care Testing (POCT) Market Share by Country (2021-2026) Table 229. Asia-Pacific Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. Asia-Pacific Point-of-Care Testing (POCT) Market Share Forecast by Country (2027-2032) Table 231. Latin America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 232. Latin America Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 233. Latin America Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2026) Table 234. Latin America Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032) & (M Units) Table 235. Latin America Point-of-Care Testing (POCT) Sales Market Share Forecast by Country (2027-2032) Table 236. Latin America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 237. Latin America Point-of-Care Testing (POCT) Market Size by Country (2021-2026) & (US$ Million) Table 238. Latin America Point-of-Care Testing (POCT) Market Share by Country (2021-2026) Table 239. Latin America Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 240. Latin America Point-of-Care Testing (POCT) Market Share Forecast by Country (2027-2032) Table 241. Middle East and Africa Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 242. Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2021-2026) & (M Units) Table 243. Middle East and Africa Point-of-Care Testing (POCT) Sales Market Share by Country (2021-2026) Table 244. Middle East and Africa Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032) & (M Units) Table 245. Middle East and Africa Point-of-Care Testing (POCT) Sales Market Share Forecast by Country (2027-2032) Table 246. Middle East and Africa Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 247. Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country (2021-2026) & (US$ Million) Table 248. Middle East and Africa Point-of-Care Testing (POCT) Market Share by Country (2021-2026) Table 249. Middle East and Africa Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 250. Middle East and Africa Point-of-Care Testing (POCT) Market Share Forecast by Country (2027-2032) Table 251. Key Raw Materials Table 252. Raw Materials Key Suppliers Table 253. Point-of-Care Testing (POCT) Distributors List Table 254. Point-of-Care Testing (POCT) Customers List Table 255. Research Programs/Design for This Report Table 256. Authors List of This Report Table 257. Secondary Sources Table 258. Primary Sources List of Figures Figure 1. Point-of-Care Testing (POCT) Image Figure 2. Global Point-of-Care Testing (POCT) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Point-of-Care Testing (POCT) Market Size (2021-2032) & (US$ Million) Figure 4. Global Point-of-Care Testing (POCT) Sales (2021-2032) & (M Units) Figure 5. Blood Glucose Testing Image Figure 6. Global Blood Glucose Testing Sales YoY Growth (2021-2032) & (M Units) Figure 7. Infectious Diseases Testing Image Figure 8. Global Infectious Diseases Testing Sales YoY Growth (2021-2032) & (M Units) Figure 9. Cardiac Markers Testing Image Figure 10. Global Cardiac Markers Testing Sales YoY Growth (2021-2032) & (M Units) Figure 11. Coagulation Testing Image Figure 12. Global Coagulation Testing Sales YoY Growth (2021-2032) & (M Units) Figure 13. Pregnancy and Fertility Testing Image Figure 14. Global Pregnancy and Fertility Testing Sales YoY Growth (2021-2032) & (M Units) Figure 15. Blood Gas/Electrolytes Testing Image Figure 16. Global Blood Gas/Electrolytes Testing Sales YoY Growth (2021-2032) & (M Units) Figure 17. Urinalysis Testing Image Figure 18. Global Urinalysis Testing Sales YoY Growth (2021-2032) & (M Units) Figure 19. Global Point-of-Care Testing (POCT) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Point-of-Care Testing (POCT) Market Share by Type 2025 VS 2032 Figure 21. North America Point-of-Care Testing (POCT) Sales Market Share in Volume by Type in 2025 Figure 22. North America Point-of-Care Testing (POCT) Sales Market Share in Value by Type in 2025 Figure 23. Europe Point-of-Care Testing (POCT) Sales Market Share in Volume by Type in 2025 Figure 24. Europe Point-of-Care Testing (POCT) Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Point-of-Care Testing (POCT) Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Point-of-Care Testing (POCT) Sales Market Share in Value by Type in 2025 Figure 27. Latin America Point-of-Care Testing (POCT) Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Point-of-Care Testing (POCT) Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Point-of-Care Testing (POCT) Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Point-of-Care Testing (POCT) Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Point-of-Care Testing (POCT) Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Clinics Image Figure 34. Global Clinics Sales YoY Growth (2021-2032) & (M Units) Figure 35. Hospitals Image Figure 36. Global Hospitals Sales YoY Growth (2021-2032) & (M Units) Figure 37. Laboratory Image Figure 38. Global Laboratory Sales YoY Growth (2021-2032) & (M Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 41. Global Point-of-Care Testing (POCT) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Point-of-Care Testing (POCT) Market Share by Application 2025 VS 2032 Figure 43. North America Point-of-Care Testing (POCT) Sales Market Share in Volume by Application in 2025 Figure 44. North America Point-of-Care Testing (POCT) Sales Market Share in Value by Application in 2025 Figure 45. Europe Point-of-Care Testing (POCT) Sales Market Share in Volume by Application in 2025 Figure 46. Europe Point-of-Care Testing (POCT) Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Point-of-Care Testing (POCT) Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Point-of-Care Testing (POCT) Sales Market Share in Value by Application in 2025 Figure 49. Latin America Point-of-Care Testing (POCT) Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Point-of-Care Testing (POCT) Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Point-of-Care Testing (POCT) Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Point-of-Care Testing (POCT) Sales Market Share in Value by Application in 2025 Figure 53. North America Point-of-Care Testing (POCT) Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. North America Point-of-Care Testing (POCT) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Point-of-Care Testing (POCT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Point-of-Care Testing (POCT) Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Europe Point-of-Care Testing (POCT) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Point-of-Care Testing (POCT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Point-of-Care Testing (POCT) Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 62. Asia-Pacific Point-of-Care Testing (POCT) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Point-of-Care Testing (POCT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Point-of-Care Testing (POCT) Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 66. Latin America Point-of-Care Testing (POCT) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Point-of-Care Testing (POCT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Point-of-Care Testing (POCT) Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 70. Middle East and Africa Point-of-Care Testing (POCT) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Point-of-Care Testing (POCT) Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Point-of-Care Testing (POCT) Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Point-of-Care Testing (POCT) Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Urinalysis Testing
Applications
  • Clinics
  • Hospitals
  • Laboratory
  • Others
Companies covered
  • Roche
  • Abbott
  • Johnson & Johnson
  • Siemens Healthcare
  • Danaher
  • Ascensia
  • Bio-Rad Laboratories
  • BioMerieux
  • ARKRAY
  • Nova Biomedical
  • Trividia Health
  • Quidel
  • Accriva
  • OraSure Technologies
  • Helena Laboratories
  • A. Menarini Diagnostics
  • Abaxis (Zoetis)
  • Ortho Clinical Diagnostics
  • Phamatech
  • Chembio Diagnostics
  • Trinity Biotech
  • ELITech Group
  • Response Biomedical
  • Princeton BioMeditech
  • Alfa Wassermann

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Point-of-Care Testing (POCT) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Point-of-Care Testing (POCT) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Point-of-Care Testing (POCT) Market by Type
  6. 1.3.1 Blood Glucose Testing
  7. 1.3.2 Infectious Diseases Testing
  8. 1.3.3 Cardiac Markers Testing
  9. 1.3.4 Coagulation Testing
  10. 1.3.5 Pregnancy and Fertility Testing
  11. 1.3.6 Blood Gas/Electrolytes Testing
  12. 1.3.7 Urinalysis Testing
  13. 1.4 Global Point-of-Care Testing (POCT) Market Size by Type
  14. 1.4.1 Global Point-of-Care Testing (POCT) Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Point-of-Care Testing (POCT) Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Point-of-Care Testing (POCT) Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Point-of-Care Testing (POCT) Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Point-of-Care Testing (POCT) Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Point-of-Care Testing (POCT) Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Point-of-Care Testing (POCT) Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Point-of-Care Testing (POCT) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Point-of-Care Testing (POCT) Industry Trends
  2. 2.2 Point-of-Care Testing (POCT) Industry Drivers
  3. 2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
  4. 2.4 Point-of-Care Testing (POCT) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Point-of-Care Testing (POCT) Revenue (2021-2026)
  2. 3.2 Global Top Players by Point-of-Care Testing (POCT) Sales (2021-2026)
  3. 3.3 Global Top Players by Point-of-Care Testing (POCT) Price (2021-2026)
  4. 3.4 Global Point-of-Care Testing (POCT) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Point-of-Care Testing (POCT) Major Company Production Sites & Headquarters
  6. 3.6 Global Point-of-Care Testing (POCT) Company, Product Type & Application
  7. 3.7 Global Point-of-Care Testing (POCT) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Point-of-Care Testing (POCT) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier 3
4 Point-of-Care Testing (POCT) Regional Status and Outlook
  1. 4.1 Global Point-of-Care Testing (POCT) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Point-of-Care Testing (POCT) Historic Market Size by Region
  3. 4.2.1 Global Point-of-Care Testing (POCT) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Point-of-Care Testing (POCT) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Point-of-Care Testing (POCT) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Point-of-Care Testing (POCT) Forecasted Market Size by Region
  7. 4.3.1 Global Point-of-Care Testing (POCT) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Point-of-Care Testing (POCT) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Point-of-Care Testing (POCT) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Point-of-Care Testing (POCT) by Application
  1. 5.1 Point-of-Care Testing (POCT) Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Laboratory
  5. 5.1.4 Others
  6. 5.2 Global Point-of-Care Testing (POCT) Market Size by Application
  7. 5.2.1 Global Point-of-Care Testing (POCT) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Point-of-Care Testing (POCT) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Point-of-Care Testing (POCT) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Point-of-Care Testing (POCT) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Point-of-Care Testing (POCT) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Point-of-Care Testing (POCT) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Point-of-Care Testing (POCT) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Point-of-Care Testing (POCT) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Abbott
  8. 6.2.1 Abbott Company Information
  9. 6.2.2 Abbott Business Overview
  10. 6.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
  12. 6.2.5 Abbott Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Siemens Healthcare
  20. 6.4.1 Siemens Healthcare Company Information
  21. 6.4.2 Siemens Healthcare Business Overview
  22. 6.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
  24. 6.4.5 Siemens Healthcare Recent Developments
  25. 6.5 Danaher
  26. 6.5.1 Danaher Company Information
  27. 6.5.2 Danaher Business Overview
  28. 6.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
  30. 6.5.5 Danaher Recent Developments
  31. 6.6 Ascensia
  32. 6.6.1 Ascensia Company Information
  33. 6.6.2 Ascensia Business Overview
  34. 6.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
  36. 6.6.5 Ascensia Recent Developments
  37. 6.7 Bio-Rad Laboratories
  38. 6.7.1 Bio-Rad Laboratories Company Information
  39. 6.7.2 Bio-Rad Laboratories Business Overview
  40. 6.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
  42. 6.7.5 Bio-Rad Laboratories Recent Developments
  43. 6.8 BioMerieux
  44. 6.8.1 BioMerieux Company Information
  45. 6.8.2 BioMerieux Business Overview
  46. 6.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
  48. 6.8.5 BioMerieux Recent Developments
  49. 6.9 ARKRAY
  50. 6.9.1 ARKRAY Company Information
  51. 6.9.2 ARKRAY Business Overview
  52. 6.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
  54. 6.9.5 ARKRAY Recent Developments
  55. 6.10 Nova Biomedical
  56. 6.10.1 Nova Biomedical Company Information
  57. 6.10.2 Nova Biomedical Business Overview
  58. 6.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
  60. 6.10.5 Nova Biomedical Recent Developments
  61. 6.11 Trividia Health
  62. 6.11.1 Trividia Health Company Information
  63. 6.11.2 Trividia Health Business Overview
  64. 6.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
  66. 6.11.5 Trividia Health Recent Developments
  67. 6.12 Quidel
  68. 6.12.1 Quidel Company Information
  69. 6.12.2 Quidel Business Overview
  70. 6.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
  72. 6.12.5 Quidel Recent Developments
  73. 6.13 Accriva
  74. 6.13.1 Accriva Company Information
  75. 6.13.2 Accriva Business Overview
  76. 6.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
  78. 6.13.5 Accriva Recent Developments
  79. 6.14 OraSure Technologies
  80. 6.14.1 OraSure Technologies Company Information
  81. 6.14.2 OraSure Technologies Business Overview
  82. 6.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
  84. 6.14.5 OraSure Technologies Recent Developments
  85. 6.15 Helena Laboratories
  86. 6.15.1 Helena Laboratories Company Information
  87. 6.15.2 Helena Laboratories Business Overview
  88. 6.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
  90. 6.15.5 Helena Laboratories Recent Developments
  91. 6.16 A. Menarini Diagnostics
  92. 6.16.1 A. Menarini Diagnostics Company Information
  93. 6.16.2 A. Menarini Diagnostics Business Overview
  94. 6.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  96. 6.16.5 A. Menarini Diagnostics Recent Developments
  97. 6.17 Abaxis (Zoetis)
  98. 6.17.1 Abaxis (Zoetis) Company Information
  99. 6.17.2 Abaxis (Zoetis) Business Overview
  100. 6.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
  102. 6.17.5 Abaxis (Zoetis) Recent Developments
  103. 6.18 Ortho Clinical Diagnostics
  104. 6.18.1 Ortho Clinical Diagnostics Company Information
  105. 6.18.2 Ortho Clinical Diagnostics Business Overview
  106. 6.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  108. 6.18.5 Ortho Clinical Diagnostics Recent Developments
  109. 6.19 Phamatech
  110. 6.19.1 Phamatech Company Information
  111. 6.19.2 Phamatech Business Overview
  112. 6.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
  114. 6.19.5 Phamatech Recent Developments
  115. 6.20 Chembio Diagnostics
  116. 6.20.1 Chembio Diagnostics Company Information
  117. 6.20.2 Chembio Diagnostics Business Overview
  118. 6.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
  120. 6.20.5 Chembio Diagnostics Recent Developments
  121. 6.21 Trinity Biotech
  122. 6.21.1 Trinity Biotech Company Information
  123. 6.21.2 Trinity Biotech Business Overview
  124. 6.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
  126. 6.21.5 Trinity Biotech Recent Developments
  127. 6.22 ELITech Group
  128. 6.22.1 ELITech Group Company Information
  129. 6.22.2 ELITech Group Business Overview
  130. 6.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
  132. 6.22.5 ELITech Group Recent Developments
  133. 6.23 Response Biomedical
  134. 6.23.1 Response Biomedical Company Information
  135. 6.23.2 Response Biomedical Business Overview
  136. 6.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
  138. 6.23.5 Response Biomedical Recent Developments
  139. 6.24 Princeton BioMeditech
  140. 6.24.1 Princeton BioMeditech Company Information
  141. 6.24.2 Princeton BioMeditech Business Overview
  142. 6.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
  144. 6.24.5 Princeton BioMeditech Recent Developments
  145. 6.25 Alfa Wassermann
  146. 6.25.1 Alfa Wassermann Company Information
  147. 6.25.2 Alfa Wassermann Business Overview
  148. 6.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
  150. 6.25.5 Alfa Wassermann Recent Developments
7 North America by Country
  1. 7.1 North America Point-of-Care Testing (POCT) Sales by Country
  2. 7.1.1 North America Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Point-of-Care Testing (POCT) Sales by Country (2021-2026)
  4. 7.1.3 North America Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Point-of-Care Testing (POCT) Market Size by Country
  6. 7.2.1 North America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Point-of-Care Testing (POCT) Market Size by Country (2021-2026)
  8. 7.2.3 North America Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Point-of-Care Testing (POCT) Sales by Country
  2. 8.1.1 Europe Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Point-of-Care Testing (POCT) Sales by Country (2021-2026)
  4. 8.1.3 Europe Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Point-of-Care Testing (POCT) Market Size by Country
  6. 8.2.1 Europe Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Point-of-Care Testing (POCT) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Point-of-Care Testing (POCT) Sales by Country
  2. 9.1.1 Asia-Pacific Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Point-of-Care Testing (POCT) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Point-of-Care Testing (POCT) Market Size by Country
  6. 9.2.1 Asia-Pacific Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Point-of-Care Testing (POCT) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Point-of-Care Testing (POCT) Sales by Country
  2. 10.1.1 South America Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Point-of-Care Testing (POCT) Sales by Country (2021-2026)
  4. 10.1.3 South America Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Point-of-Care Testing (POCT) Market Size by Country
  6. 10.2.1 South America Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Point-of-Care Testing (POCT) Market Size by Country (2021-2026)
  8. 10.2.3 South America Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country
  2. 11.1.1 Middle East and Africa Point-of-Care Testing (POCT) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Point-of-Care Testing (POCT) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Point-of-Care Testing (POCT) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country
  6. 11.2.1 Middle East and Africa Point-of-Care Testing (POCT) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Point-of-Care Testing (POCT) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Point-of-Care Testing (POCT) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Point-of-Care Testing (POCT) Value Chain Analysis
  2. 12.1.1 Point-of-Care Testing (POCT) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Point-of-Care Testing (POCT) Production Mode & Process
  7. 12.2 Point-of-Care Testing (POCT) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Point-of-Care Testing (POCT) Distributors
  10. 12.2.3 Point-of-Care Testing (POCT) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst